Table 3.
Effect of the pituitary suppression and COS protocol on incidence of immature oocytes
| GnRH agonist | GnRH antagonista | ||||||
|---|---|---|---|---|---|---|---|
| rFSH (n=658) | rFSH plus rLH (n=712) | P | rFSH (n=1,570) | rFSH plus rLH (n=980) | p | ||
| MI | 1.45±0.10 | 0.38±0.68 | 0.119 | 1.13±0.03 | 1.12±0.05 | 0.928 | |
| GV | 1.46±0.14 | 0.40±0.93 | 0.263 | 1.33±0.05 | 1.36±0.08 | 0.731 | |
| MI/oocyte | 13.40±0.91 | 6.32±6.19 | 0.147 | 10.75±0.36 | 11.33±0.59 | 0.405 | |
| GV/oocyte | 11.52±1.12 | 1.86±2.10 | <0.001 | 11.01±0.36 | 5.93±5.40 | 0.042 | |
GnRH: gonadotropin-releasing hormone;
FSH: follicle stimulating hormone;
LH: luteinizing hormone.
*
Data was adjusted for maternal age, maternal BMI, total FSH dose